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Abstract
Background: Excessive weight is a well-known risk factor for microvascular diseases. Changes in thickness in a
vascular tissue, such as the choroid, can be useful to evaluate the effect of obesity on the microvascular system.
The aim of this study was to evaluate the choroidal thickness (CT) changes in obese women, using optical
coherence tomography (OCT).
Methods: The prospective clinical study included examination of the right eyes of 72 patients. The right eyes of 68
patients were examined and served as the controls. A complete ophthalmological examination and OCT imaging
were performed for each group studied. The CT in each eye was measured using OCT.
Results: The obese group consisted of 72 female patients with a mean age of 37.27 ± 1.18 years. The control group
included 68 female subjects with a mean age of 37.85 ± 7.98 years (p > 0.05). There was no statistical significant
difference for the foveal retinal thickness measurements between the two groups (p > 0.5). Our study revealed
significant choroidal tissue thickening subfoveally and at areas 500 μm temporal, 500 μm nasal, and 1500 μm nasal
to the fovea in the obese group (all p < 0.05). There was a positive correlation between body mass index (BMI) and
CT changes.
Conclusions: CT may increase in obese women and a positive correlation was found between BMI and CT.
The trial protocol was approved by the Local Ethical Committee of the Kırıkkale University, date of registration:
April 27, 2015 (registration number: 10/11).
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Background
Obesity is a common health problem and its prevalence
is increasing worldwide [1–3]. Excessive weight is a well-
known risk factor for diabetes, hypertension, dyslipid-
emia, and microvascular diseases [4–6], including retinal
vasculature [7, 8]. One of the main concerns with obes-
ity is that microvascular alterations cannot be diagnosed
in the early stages. Although many studies have investi-
gated the comorbidities associated with obesity [9–11],
predicting the risk of developing vascular damage re-
mains challenging.
The association of obesity with cataract formation,
glaucoma, and age-related macular degeneration has been
shown in varying degrees. Researchers have hypothesized
that retinal microvascular changes are precursors to devel-
oping obesity based on experimental and clinical observa-
tions [12, 13]. In the Blue Mountains Eye Study, retinal
vessel diameter was associated with the prevalence of
higher body mass index (BMI) and the increased risk of
incident obesity [14].
In the eye, the choroid, the posterior portion of the
uveal tract, nourishes the outer portion of the retina. It
contributes to the blood supplied to the prelaminar por-
tion of the optic nerve [1], is an integral constituent in
the functioning of the eye, and is involved in important
diseases affecting the optic nerve, retinal pigment epithe-
lium, and the retina. By using enhanced depth imaging
optical coherence tomography (EDI-OCT), choroid im-
ages can be obtained and the choroidal thickness (CT)
can be measured [3].
Previous studies have suggested that a higher BMI can
trigger structural changes in the retinal vascular system that
could provoke retinal dysfunction, as shown in aged-related
macular degeneration or diabetic retinopathy. Therefore,
knowledge of the thickness changes in a vascular tissue,
such as the choroid, may help to evaluate the effect of obes-
ity on the microvascular system.
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The prevalence of obesity among men and women var-
ies greatly within, and between countries, with more
obesity found in women than in men. This gender dis-
parity in obese population is exacerbated among women
in developing countries. In the TURDEP study, which
investigated 24,788 people >20 years old in Turkey, the
prevalence of obesity in women was 29.9, and 12.9 % in
men [15].
Therefore, in the present study, we hypothesized that
obesity is correlated with CT changes, particularly in
women. To the best of our knowledge, this is the first
study evaluating CT in obese female patients.
Methods
This prospective clinical study included the examination
of the right eyes of 72 patients. In total, 68 right eyes of 68
patients were examined and served as controls. The study
was conducted between 2015 and 2016 in accordance with
the tenets of the Declaration of Helsinki. The trial proto-
col was approved by the Local Ethical Committee of the
University of Kırıkkale. Registration of the trial was
requested on April 27th, 2015 (decision no:10/11). All
patients and control subjects voluntarily participated in
the study and signed an informed consent form. The
obese group was classified according to the World Health
Organisation criteria; (BMI 18.5–24.9 kg/m2 = normal;
25.0–29.9 kg/m2 = pre-obese/overweight, and ≥30.0 kg/
m2 = obese).
In the study, the obese group included patients who had
a BMI > 30 kg/m2, without any other disease, whereas
healthy adults with BMI <25 kg/m2 constituted the con-
trol group. Obese patients were randomly selected from
those monitored by the Department of Endocrinology.
The exclusion criteria were as follows: a previous systemic
or chronic disease such as hypertension, smoking, ocular
surgery in one or both eyes; axial length >24 ± 1.0 mm;
and a refractive measurement > 2.0 diopters.
All participants underwent a complete ocular examin-
ation, including a best-corrected visual acuity measure-
ment, slit-lamp examination, intraocular pressure
measurement, and dilated fundoscopy. Only the right
eyes of each of the patients were selected to avoid any
intra-individual bias.
The CT was measured as close to noon as possible to
avoid diurnal variations. The measurements were per-
formed using anEDI-OCT scanning system (OCT Advance
Nidek RS-3000; Nidek Co. Ltd., Gamagori, Japan). Prior to
evaluation using EDI-OCT scanning, the central macular
thickness was measured in the right eye of each patient.
Choroidal and scleral boundaries were drawn with the as-
sistance of software programs. The boundaries limited the
Bruch membrane, between the subfoveal points (FCT), to
500 and 1500 μm in the nasal regions (N500, N1500) and
500 and 1500 μm in the temporal regions (T500, T1500),
for CT measurements. All measurements including the
demarcation of the choroid and sclera were made by two
independent (masked) observers. There were no significant
differences between the results of the two observers
(p = 0.317: Paired t-test, r = 0.716 and p 0.001:Pear-
son’s correlation), and the average of the two results
was used in our analyses.
Statistical analyses were performed using the SSPS
statistical software (SPSS for Windows 23.0, Inc.,
Chicago, USA). The results of the descriptive ana-
lysis were provided in numbers, percentages, mean,
median, and standard deviations. A paired t-test was
used to assess the difference in the means of the
observers’ measurements to test the repeatability and
accuracy of the two independent measurements. The
independent t-test was used to compare the variables
between the obese group and the control group, and
correlations were performed using Pearson’s correl-
ation coefficient. A multiple linear regression ana-
lysis (forward) was used to determine confounding
factors among the variables. p < 0.05 was considered
statistically significant.
Results
The study group consisted of 140 female (100 %) sub-
jects, with a mean age of 37.55 ± 1.01 years (median:38;
range:21–59 years). There were 72 patients in the obese
group, with a mean age of 37.27 ± 1.18 years (median:
38.5; range 21–59 years). The control group included 68
subjects, with a mean age of 37.85 ± 7.98 years (me-
dian:38; range 24–54 years). There was no significant dif-
ference, in terms of age, between the two groups (p > 0.5).
Demographics of the study groups are shown in Table 1.
There was no significant difference found for foveal
retinal thickness (FT) when the two groups were com-
pared (p > 0.5). In contrast, the CT revealed significant
differences at FCT, T500, N500, and N1500 between the
two groups (all p < 0.05). Changes in both FT and CT are
demonstrated in Table 2.
There was a positive correlation found between
BMI and CT at FCT, T500, and N500 (Table 3).
Multiple linear regression analysis revealed that CT
had been affected by BMI independently from the
aspect of age of the patient (Table 4).
Table 1 Demographics of the groups
Group Age BMI (Kg/m2) Weight (kg) Height (cm)
1(N = 72) 37.27 ± 11.81 39.16 ± 6.88 100.63 ± 16.49 160.42 ± 6.20








BMI body mass index
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Discussion
In the eye, CT may be affected by several factors, such as
age, axial length, and refractive errors [16, 17]. Diurnal
changes in CT have also been reported [18]. It is believed
that systemic blood pressure and intraocular pressure
induce choroidal tissue changes through an autoregulatory
mechanism [19]. Therefore, because the choroid possesses
a rich vascular structure, all of the aforementioned factors
have the potential to alter the CT [20].
A study by Tanabe et al., demonstrated a significant cor-
relation between choroidal vein diameter and the CT [21].
Another investigation by Vance et al., reported that
phosphodiesterase-5 inhibitors, such as sildenafil citrate,
increased CT via a smooth muscle relaxation effect [22]. In
a study by Wong et al., CT was found to be thicker in
hypercholesterolemic patients [23]. This study had a cross-
sectional design with only Chinese subjects; therefore, their
results may not address the issue of any ethnic differences
in CT. It is of interest that Regatieri et al., found that the
choroid was thinner among subjects with diabetic retinop-
athy [24]. However, a previously observed inverse correl-
ation between age and CT might have affected this
correlation [25]. A number of studies have found that CT
plays a prognostic or predictive role in various local (for ex-
ample, diabetic retinopathy, and AMD), and systemic dis-
eases (for example, hypertension, anemia, and rheumatoid
arthritis) [24, 26–33].
Jongh et al., reported the effects of obesity on the micro-
vascular system; hyperinsulinemia and elevated blood pres-
sure were found to be the major causes of the vascular
alterations in obese women [4]. In another study by Kawa-
saki et al., both retinal venous and arterial dilatation were
found in hypertensive patients [7]. Research by Saito et al.,
studied the retinal venous system in 900 subjects and
reported an incidence of 5 years of obesity in some patients
[34]. The authors found a positive correlation between
vessel caliber and BMI; however, no correlation was shown
between these changes and the development of obesity.
In this study, CT was found to be significantly reduced
in the non-obese controls, except for the temporal meas-
urement of 1500 μm. It was an interesting finding be-
cause as shown in recent studies, we expected a
subfoveal or temporal change in CT. Previous studies re-
ported that the macula demonstrated a thin choroid
layer in the nasal region [35, 36]. Another possibility for
this regional difference may be a result of the develop-
mental pattern of the eye.
In the light of previous reports, we hypothesized that
there is a relationship between obesity and the choroidal
layer of the eye. In the present study, the obesity group
consisted of patients with a BMI > 30, and subjects with
a BMI < 25 constituted the control group. To avoid any
diurnal effect, we performed all the measurements at
noon for each patient. We also excluded patients with a
history of local and systemic diseases. Although no sig-
nificant differences were found for FT between the
groups, there was a significant increase in CT at certain
points (CFT, nasal 500, and 1500 μm, and temporal
500 μm) in the obese group. The results indicated that
there was a positive correlation between BMI and CT,
and multiple linear regression analysis revealed that CT
was independently affected by the age of the patients.
Table 2 Changes in foveal thickness and choroidal thickness
Group Group FCT T500 T1500 N500 N1500
1(N = 72) 250.1 ± 19.8 349.2 ± 58.7 346.5 ± 55.1 335.8 ± 55.1 345.5 ± 59.7 327.0 ± 55.3
2(N = 68) 256.0 ± 18.9 322.7 ± 37.8 317.3 ± 39.7 313.6 ± 39.7 323.3 ± 39.5 322.2 ± 37.7
P =0.185 P =0.002 P =0.014 P =0.230 P <0.001 P <0.001
FCT: choroidal thickness at fovea; N500, choroidal thickness at 500 μm nasal to the fovea; N1500, choroidal thickness at 1500 μm nasal to the fovea; T500,
choroidal thickness at 500 μm temporal to the fovea; T1500, choroidal thickness at 1500 μm temporal to the fovea; FT: central macular thickness
Table 3 The Pearson Correlation analysis between body mass
index - Choroidal thickness and foveal thickness
AGE FCT N500 N1500 T500 T1500 FT
r = 0.125 r = 0.198 r = 0.193 r = 0.082 r = 0.206 r = 0.151 r = −0.162
P =0.140 P =0.019 P =0.022 P =0.334 P =0.015 P =0.076 P =0.056
FCT: choroidal thickness at fovea; N500, choroidal thickness at 500 μm nasal to
the fovea; N1500, choroidal thickness at 1500 μm nasal to the fovea; T500,
choroidal thickness at 500 μm temporal to the fovea; T1500, choroidal
thickness at 1500 μm temporal to fovea; FT: central macular thickness
Table 4 Multiple linear regression analysis between choroidal
thickness, age and Body mass index
Beta (β) P
N500 BMI 0.233 0.004
Age −0.317 <0.001
N1500 BMI 0.249 0.011
Age −0.325 0.012
T500 BMI −0.402 0.001
Age −0.289 <0.001
T1500 BMI 0.204 0.009
age −0.423 <0.001
FCT BMI 0.243 0.002
Age −0.364 <0.001
FCT: choroidal thickness at fovea; N500, choroidal thickness at 500 μm nasal to
the fovea; N1500, choroidal thickness at 1500 μm nasal to the fovea; T500,
choroidal thickness at 500 μm temporal to the fovea; T1500, choroidal
thickness at 1500 μm temporal to the fovea; BMI: Body mass index
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There were some limitations in the study, such as the
pathogenesis of obesity, which included several unknown
hormonal and genetic factors; moreover, because chor-
oid is a vascular tissue, it may be affected by local and
systemic factors. We also excluded patients with sys-
temic metabolic disorders to avoid confounding factors.
A further limitation of the study was the lack of data on
CT changes after weight loss through dietary restriction.
The prevalence of obesity among women is greater than
that in men, which we found to be the same for the pa-
tients in our Department of Endocrinology. Due to the
difficulty in making homogenous groups of obese pa-
tients of both genders and the fact that choroidal tissue
may be different in both genders, we decided to include
only females in our study. Indeed, it may be proposed
that obese male patients also have choroidal changes;
therefore, further studies with male patients are war-
ranted in the future.
Conclusion
In summary, our data provides evidence for a relation-
ship between CT and obesity in female patients. Vascular
abnormalities may occur at early stages in obesity and
ocular circulation may be a preferred target for the dis-
ease process. The assessment of CT is a quick and non-
invasive technique, which can be utilized to determine
such abnormalities. Meanwhile, it is unclear how this
data may be applied to individual patients and how it
can benefit obesity management. The data suggests that
CT measurement has a predictive role and BMI should
be included among the parameters that may affect CT
results in obese women. A prospective follow-up study
with a large sample size is required to test our hypoth-
esis and to verify the results of the present clinical study.
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